Related Experiment Videos

Low molecular weight heparins: are they interchangeable? No

¹Division of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Italy. medvasc@unipg.it

Journal of Thrombosis and Haemostasis : JTH

|July 23, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Original Article: Albumin Prevents TxB, Formation from Thrombin-stimulated Human Platelets by Sequestering the Liberated Arachidonic Acid in the Extracellular Space.

Platelets·2010

Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism.

Current pharmaceutical design·2005

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.

Thrombosis and haemostasis·2002

Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.

Haematologica·2001

Low molecular weight heparins for arterial thrombosis.

Vascular medicine (London, England)·2001

Antithrombotic drugs for the secondary prevention of ischemic stroke.

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2001

See all related articles